{ "model": { "rank": 1392, "code": "thing-q51993", "model_id": "vr.tr.ebola-hemorrhagic-fever", "name": "Ebola hemorrhagic fever", "purpose": "Enable an AI agent to recognise Ebola hemorrhagic fever, assess the evidence and course of a disease occurrence, and identify actions requiring clinical or public-health authority.", "family": "Thing Registry", "category": "Cross-cutting context", "status": "research-draft", "kind": "thing", "plane": "XCT", "domain": "XCT.QLT", "industry": "", "version": "", "url": "/models/thing/q51993/", "tier": 2, "score": 150, "payload": { "layer": "wikidata", "aliases": [], "aliasCount": 0, "merged": 0, "knownIn": 150, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q51993", "url": "https://www.wikidata.org/wiki/Q51993", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-07T11:26:41Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 28.8, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.3\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a07b9d-7b60-73b2-8acb-c1c3c295fe56\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: Ebola hemorrhagic fever\nSense to describe: (none recorded)\nDomain code: XCT.STA\nAlso known as: (none)\n\n\nContext for this batch of 210 things:\n# Batch 00", "usd": 0, "recall": true }, "codex": { "seconds": 88.5, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.3\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a07b9d-7af5-7553-98d8-ac63b466c191\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: Ebola hemorrhagic fever\nRegistry id: vr.tr.ebola-hemorrhagic-fever\nPlane / domain: XCT / XCT.STA\nRegistry definition: (none recorded)\nNames folded in" } } }, "metaModel": { "id": "THING-Q51993", "registryId": "vr.tr.ebola-hemorrhagic-fever", "name": "Ebola hemorrhagic fever", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "XCT.STA" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q51993/", "model": { "registry_id": "vr.tr.ebola-hemorrhagic-fever", "name": "Ebola hemorrhagic fever", "purpose": "Enable an AI agent to recognise Ebola hemorrhagic fever, assess the evidence and course of a disease occurrence, and identify actions requiring clinical or public-health authority.", "definition": "Ebola hemorrhagic fever is a historical name for Ebola disease, a severe infectious illness caused by certain viruses of the genus Ebolavirus that can cause systemic inflammation, gastrointestinal fluid loss, shock and organ dysfunction, with bleeding occurring in some but not all patients.", "scope_statement": "This draft models vr.tr.ebola-hemorrhagic-fever in XCT/XCT.STA as the human disease concept historically called Ebola hemorrhagic fever, provisionally covering Ebola diseases while recording the causative virus explicitly; it separates the condition from diagnostic assertions, patients, and episodes of care.", "in_scope": [ "Historical naming, current disease terminology, and versioned classification mappings", "Causative virus attribution and exposure evidence", "Case classification, laboratory evidence, and differential diagnosis", "Clinical course, severity, recovery, and disease-related persistence", "Disease-specific constraints on care, infection prevention, and public-health response", "Population burden with geographic, temporal, and case-definition context" ], "out_of_scope": [ "The patient's complete health record and identity", "Hospital visits, admissions, staffing, and billing", "Virus taxonomy, genomes, and laboratory propagation as independent models", "Outbreak logistics and contact-tracing operations as independent processes", "Vaccine and therapeutic product manufacturing or full prescribing specifications", "Independent models of Marburg disease, malaria, and other differential diagnoses" ], "distinguishing_features": [ "Require compatible evidence of an Ebola-causing virus to distinguish confirmed disease from clinically similar infections; symptoms alone cannot establish the cause. [WHO Ebola questions and answers](https://www.who.int/news-room/questions-and-answers/item/ebola-disease)", "Do not require hemorrhage: bleeding is less frequent and may occur later, despite the historical name. [WHO Ebola fact sheet](https://www.who.int/news-room/fact-sheets/detail/ebola-disease)", "Record whether a source means Ebola disease broadly or Ebola virus disease specifically; current WHO terminology distinguishes Ebola virus, Sudan virus, and Bundibugyo virus diseases. [WHO Ebola fact sheet](https://www.who.int/news-room/fact-sheets/detail/ebola-disease)", "Distinguish an exposed contact from a disease occurrence, and a suspected case from a laboratory-confirmed case.", "Distinguish acute disease, post-acute symptoms, and evidence of viral persistence rather than assigning them one undifferentiated state." ], "characteristics": [ { "name": "Disease-name interpretation", "kind": "category", "unit_or_values": "Historical umbrella term; virus-specific disease term; unresolved", "why_it_matters": "Prevents historical labels from silently imposing a narrower or broader disease boundary." }, { "name": "Causative virus attribution", "kind": "relation", "unit_or_values": "Named virus linked to laboratory evidence and taxonomy version; undetermined", "why_it_matters": "Supports diagnosis and assessment of virus-specific intervention applicability." }, { "name": "Case classification", "kind": "state", "unit_or_values": "Authority-defined suspected, probable, confirmed, excluded, or unresolved status with definition version and assessment date", "why_it_matters": "Separates evidence strength from disease severity." }, { "name": "Exposure-to-onset interval", "kind": "measurement", "unit_or_values": "Days or bounded interval, with uncertainty in exposure and onset dates", "why_it_matters": "Supports assessment of epidemiological compatibility without treating an uncertain exposure date as exact." }, { "name": "Laboratory evidence", "kind": "relation", "unit_or_values": "Test record with method, viral target, specimen type, collection time, result, and interpretation authority", "why_it_matters": "Makes confirmation and exclusion dependent on interpretable evidence." }, { "name": "Clinical course", "kind": "state", "unit_or_values": "Acute illness; convalescence; resolved acute illness; possible recurrence; fatal outcome; unresolved", "why_it_matters": "Separates temporal course from diagnostic confidence and discharge status." }, { "name": "Hemorrhagic manifestations", "kind": "state", "unit_or_values": "Present with site and onset; absent on assessment; not assessed", "why_it_matters": "Records bleeding without making it a defining requirement." }, { "name": "Physiological severity", "kind": "measurement", "unit_or_values": "Timestamped clinical observations and laboratory measurements with native units and referenced assessment criteria", "why_it_matters": "Supports recognition of deterioration without inventing a universal Ebola severity score." }, { "name": "Persistence evidence", "kind": "relation", "unit_or_values": "Anatomical compartment, specimen, assay, date, result, and interpretation", "why_it_matters": "Prevents recovery, detection of viral material, and infectiousness from being treated as equivalent." }, { "name": "Population burden", "kind": "measurement", "unit_or_values": "Cases, incidence per stated population and period, prevalence if appropriate, or case-fatality proportion with numerator and denominator", "why_it_matters": "Prevents outbreak-specific estimates from becoming timeless disease constants." } ], "affordances": [ "Resolve historical terminology against a versioned disease classification while preserving uncertain mappings.", "Assess whether available evidence satisfies a named case definition and identify missing evidence.", "Summarise disease progression and flag observations requiring clinician review under an applicable protocol.", "Identify relevant infection-prevention and notification pathways for review by responsible authorities.", "Check whether a proposed treatment or vaccination pathway matches the attributed virus, population, jurisdiction, and guidance date.", "Compare burden estimates only after aligning case definitions, populations, periods, and outcome completeness." ] }, "sources": [], "structure": { "bundles": [ { "id": "disease-identity-and-boundaries", "name": "Disease identity and boundaries", "description": "Resolve what the historical registry label denotes.", "rationale": "The name can conceal differences between an umbrella disease concept, a virus-specific disease, and a hemorrhagic presentation.", "layers": [ { "id": "historical-and-current-terminology", "name": "Historical and current terminology", "description": "Preserve the source's intended meaning when normalising names.", "findings": [ { "id": "historical-name-scope", "name": "Historical name scope", "description": "Determine the registry label's extension without requiring bleeding or silently restricting it to one virus.", "questions": [ { "text": "Does the originating registry source use Ebola hemorrhagic fever for all human Ebola diseases or a particular virus-specific disease?", "kind": "definition", "id": "historical-name-scope-q01" }, { "text": "Which dated authority supports the mapping between the historical name and current terminology?", "kind": "provenance", "id": "historical-name-scope-q02" } ] } ] }, { "id": "classification-and-instance-boundaries", "name": "Classification and instance boundaries", "description": "Separate concept mappings from assertions about individual disease occurrences.", "findings": [ { "id": "versioned-codes-and-assertions", "name": "Versioned codes and assertions", "description": "Attach classification editions and mapping precision while keeping diagnosis and care episodes distinct.", "questions": [ { "text": "Which ICD-10, ICD-11, and SNOMED CT concepts match this scope, in which releases or national editions, and with what mapping precision?", "kind": "provenance", "id": "versioned-codes-and-assertions-q01" }, { "text": "How is one disease occurrence linked to changing diagnostic assertions and multiple care episodes without becoming identical to any of them?", "kind": "boundary", "id": "versioned-codes-and-assertions-q02" } ] } ] } ] }, { "id": "causation-and-exposure", "name": "Causation and exposure", "description": "Connect disease attribution to viral and epidemiological evidence.", "rationale": "A virus attribution and an exposure history answer different questions and must not substitute for each other.", "layers": [ { "id": "viral-attribution", "name": "Viral attribution", "description": "Represent the causative agent at the resolution supported by evidence.", "findings": [ { "id": "supported-agent-identification", "name": "Supported agent identification", "description": "Distinguish laboratory-supported identification from attribution inferred from an outbreak.", "questions": [ { "text": "Which virus is supported by the available test evidence, and what identification resolution does the assay permit?", "kind": "measurement", "id": "supported-agent-identification-q01" }, { "text": "Is attribution established for this occurrence or inferred from an epidemiologically linked outbreak?", "kind": "provenance", "id": "supported-agent-identification-q02" } ] } ] }, { "id": "exposure-compatibility", "name": "Exposure compatibility", "description": "Record plausible exposure routes and their temporal uncertainty.", "findings": [ { "id": "exposure-route-and-timing", "name": "Exposure route and timing", "description": "Evaluate contact circumstances without treating location or association as proof of infection.", "questions": [ { "text": "What contact with a potentially infectious person, body, animal, fluid, or contaminated material is documented, and by whom?", "kind": "provenance", "id": "exposure-route-and-timing-q01" }, { "text": "What exposure interval and symptom-onset uncertainty must be evaluated against the applicable incubation guidance?", "kind": "measurement", "id": "exposure-route-and-timing-q02" } ] } ] } ] }, { "id": "recognition-and-diagnostic-evidence", "name": "Recognition and diagnostic evidence", "description": "Support case assessment without confusing screening with confirmation.", "rationale": "Ebola assessment must reconcile nonspecific illness, epidemiology, laboratory evidence, and changing case definitions.", "layers": [ { "id": "case-definition-and-differential", "name": "Case definition and differential", "description": "Make case status traceable to an issuing authority and competing explanations.", "findings": [ { "id": "case-classification-basis", "name": "Case classification basis", "description": "Record satisfied, missing, and contradictory criteria separately from alternative diagnoses.", "questions": [ { "text": "Which issuing body, jurisdiction, outbreak context, and revision define the assigned suspected, probable, or confirmed status?", "kind": "provenance", "id": "case-classification-basis-q01" }, { "text": "What evidence distinguishes Ebola from Marburg disease, malaria, and other plausible causes, while allowing co-infection?", "kind": "boundary", "id": "case-classification-basis-q02" } ] } ] }, { "id": "test-interpretation", "name": "Test interpretation", "description": "Interpret results in relation to specimen, assay, and illness timing.", "findings": [ { "id": "confirmation-and-exclusion-evidence", "name": "Confirmation and exclusion evidence", "description": "Require an explicit evidential basis for confirmation, exclusion, or continued uncertainty.", "questions": [ { "text": "What were the assay target, specimen type, collection time relative to onset, result, and laboratory interpretation?", "kind": "measurement", "id": "confirmation-and-exclusion-evidence-q01" }, { "text": "Under the applicable diagnostic protocol, is this evidence sufficient for classification or does it require further assessment or repeat testing?", "kind": "action", "id": "confirmation-and-exclusion-evidence-q02" } ] } ] } ] }, { "id": "clinical-course-and-outcomes", "name": "Clinical course and outcomes", "description": "Track acute disease and its outcome without imposing a mandatory symptom sequence.", "rationale": "Hemorrhage alone cannot describe severity, and resolution of acute illness does not settle every subsequent disease-related concern.", "layers": [ { "id": "acute-progression", "name": "Acute progression", "description": "Track manifestations, physiological changes, and deterioration.", "findings": [ { "id": "severity-over-time", "name": "Severity over time", "description": "Represent gastrointestinal losses, hydration, circulation, bleeding, and organ dysfunction as dated observations.", "questions": [ { "text": "When did symptoms begin, and how have fluid losses, circulatory status, bleeding, and organ function changed?", "kind": "measurement", "id": "severity-over-time-q01" }, { "text": "Which observations meet a referenced protocol's escalation criteria, and who must assess them?", "kind": "action", "id": "severity-over-time-q02" } ] } ] }, { "id": "recovery-and-persistence", "name": "Recovery and persistence", "description": "Separate acute outcomes from follow-up findings and possible recurrence.", "findings": [ { "id": "post-acute-state-boundaries", "name": "Post-acute state boundaries", "description": "Maintain distinct assertions for recovery, persistent symptoms, viral detection, and suspected recurrent disease.", "questions": [ { "text": "What evidence supports recovery, death, persistent symptoms, or possible recurrent disease, and when was that outcome assessed?", "kind": "measurement", "id": "post-acute-state-boundaries-q01" }, { "text": "Which findings belong to acute Ebola, a linked sequela, viral persistence, or an unrelated condition, and what remains unresolved?", "kind": "boundary", "id": "post-acute-state-boundaries-q02" } ] } ] } ] }, { "id": "care-and-transmission-response", "name": "Care and transmission response", "description": "Identify applicable care and infection-prevention decisions.", "rationale": "Action depends on viral attribution, clinical state, guidance version, and the responsible authority.", "layers": [ { "id": "clinical-intervention-applicability", "name": "Clinical intervention applicability", "description": "Link care needs to supported intervention pathways.", "findings": [ { "id": "virus-and-population-matched-care", "name": "Virus and population matched care", "description": "Require current evidence and eligibility review for proposed disease-specific interventions.", "questions": [ { "text": "Which supportive-care needs require attention under the applicable Ebola care guidance?", "kind": "action", "id": "virus-and-population-matched-care-q01" }, { "text": "Does the proposed therapeutic or vaccine pathway apply to this virus, age group, pregnancy status, jurisdiction, and date, and is its use approved or investigational?", "kind": "boundary", "id": "virus-and-population-matched-care-q02" } ] } ] }, { "id": "infection-prevention-and-notification", "name": "Infection prevention and notification", "description": "Link case assessment to authorised protective and reporting processes.", "findings": [ { "id": "response-triggers-and-release", "name": "Response triggers and release", "description": "Represent protocol-based response triggers and distinguish discharge from clearance of every transmission concern.", "questions": [ { "text": "Which current protocol governs notification, isolation assessment, specimen referral, contact evaluation, and management after death?", "kind": "action", "id": "response-triggers-and-release-q01" }, { "text": "What authority and evidence support changing precautions or follow-up, including any compartment-specific persistence concern?", "kind": "provenance", "id": "response-triggers-and-release-q02" } ] } ] } ] }, { "id": "population-patterns-and-evidence", "name": "Population patterns and evidence", "description": "Contextualise disease burden and the limits of generalisation.", "rationale": "Outbreak counts and outcomes depend on surveillance, viral attribution, care access, and population composition.", "layers": [ { "id": "burden-and-denominators", "name": "Burden and denominators", "description": "Make epidemiological measurements comparable only where their definitions permit.", "findings": [ { "id": "contextualised-burden-estimates", "name": "Contextualised burden estimates", "description": "Preserve the population, period, geography, case categories, and completeness behind each estimate.", "questions": [ { "text": "What population, location, year or outbreak interval, case definition, and reporting date support the count or rate?", "kind": "measurement", "id": "contextualised-burden-estimates-q01" }, { "text": "Are suspected cases, unresolved outcomes, under-ascertainment, and denominator uncertainty handled explicitly in incidence, prevalence, or case-fatality estimates?", "kind": "measurement", "id": "contextualised-burden-estimates-q02" } ] } ] }, { "id": "affected-populations-and-transferability", "name": "Affected populations and transferability", "description": "Assess whether evidence applies across exposure groups and clinical populations.", "findings": [ { "id": "population-specific-evidence-limits", "name": "Population-specific evidence limits", "description": "Distinguish measured subgroup differences from assumptions based on a different outbreak or setting.", "questions": [ { "text": "Which populations are represented in evidence about occupational exposure, caregiving, childhood disease, pregnancy, and survivor outcomes?", "kind": "provenance", "id": "population-specific-evidence-limits-q01" }, { "text": "Which conclusions cannot be transferred across viruses, outbreaks, populations, or levels of care without additional evidence?", "kind": "boundary", "id": "population-specific-evidence-limits-q02" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This is recalled knowledge without source consultation; verify current virus taxonomy and whether the registry intends the historical umbrella sense or specifically Ebola virus disease.", "Verify current WHO case definitions, coding editions and virus-specific eligibility for vaccines and therapeutics before operational use.", "No prevalence or fatality estimate is supplied because these require an identified outbreak, population, period and ascertainment method." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Ebola virus disease, caused by Ebola virus", "Sudan virus disease, caused by Sudan virus", "Bundibugyo virus disease, caused by Bundibugyo virus", "Taï Forest virus disease, caused by Taï Forest virus" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "WHO ICD-10", "value_or_pattern": "A98.4", "note": "Ebola virus disease; record the ICD revision and any national modification when using this code." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-standards-and-regulation", "name": "Standards and regulation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "World Health Organization surveillance case definitions distinguish suspected, probable and confirmed Ebola cases; the applicable outbreak guidance and version must accompany their use.", "World Health Organization infection prevention and control guidance addresses care of suspected or confirmed cases and safe management of bodies.", "The International Health Regulations (2005), issued by the World Health Organization, provide a framework for assessing and notifying events that may constitute an international public health emergency." ], "questions": [ { "id": "evidence-standards-and-regulation-q01", "text": "Which of these standards and regulation hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Recognition, isolation and laboratory investigation of suspected cases.", "Outbreak surveillance, contact tracing and monitoring of exposed people.", "Clinical management of fluid losses, electrolyte disturbances, shock and organ dysfunction.", "Selection of virus-specific vaccination or treatment strategies where supported.", "Follow-up of survivors for persistent symptoms and possible viral persistence." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Incubation period", "typical_range": "2-21", "unit": "days" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Early symptoms are nonspecific and can be mistaken for malaria or other febrile illnesses.", "Requiring visible bleeding for recognition misses cases because hemorrhage is not universal.", "Direct contact with infected blood, other infectious body fluids or contaminated materials can transmit infection, including during care and burial.", "Severe vomiting and diarrhea can cause dehydration, electrolyte disturbances and shock.", "Virus can persist in certain body compartments after recovery; subsequent sexual transmission has been documented." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Recognized outbreaks have predominantly occurred in sub-Saharan Africa; the causative virus differs among outbreaks.", "Observed outcomes vary with access to timely diagnosis, supportive care and virus-specific interventions." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Marburg virus disease", "difference": "A related filovirus disease with overlapping clinical features, distinguished by identification of the causative virus." }, { "name": "Viral hemorrhagic fever", "difference": "A broader disease grouping that includes Ebola disease and illnesses caused by other virus families." }, { "name": "Ebola virus", "difference": "The infectious agent responsible for one form of Ebola disease, rather than the disease itself." }, { "name": "Malaria", "difference": "A parasitic infection that can resemble early Ebola disease clinically; pathogen-specific testing distinguishes them, and coinfection is possible." }, { "name": "Post-Ebola syndrome", "difference": "Persistent or delayed health problems following survival of acute Ebola disease, rather than the acute illness." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of Ebola hemorrhagic fever this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Does the originating registry intend the historical umbrella sense or the narrower current Ebola virus disease sense, and does an existing world model already own that concept?", "What exact ICD-10, ICD-11, and SNOMED CT mappings are valid for the resolved scope, with editions, releases, and mapping limitations?", "Which current jurisdictional case definitions, diagnostic protocols, and precaution-release criteria should anchor operational assessments?", "Which virus-specific therapies and vaccines are currently supported or authorised for relevant populations, and where is evidence limited to investigational use?", "Which population datasets can support comparable burden and survivor-outcome estimates, and where do ascertainment or follow-up gaps prevent reliable conclusions?" ], "statistics": { "bundles": 7, "layers": 13, "findings": 21, "questions": 33 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "disease or condition", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a Ebola hemorrhagic fever, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an AI agent to recognise Ebola hemorrhagic fever, assess the evidence and course of a disease occurrence, and identify actions requiring clinical or public-health authority.", "characteristics": { "substance": "abstract", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Described in 150 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a Ebola hemorrhagic fever, and on what evidence are they told apart?" ], "whatItIsMadeOf": "an abstraction with no physical instance", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Recognised by criteria applied to signs and findings, not by appearance. Two conditions can look identical and be distinguished only by test." ], "relatedModels": [], "standing": "Described in 150 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one Ebola hemorrhagic fever from another, and a Ebola hemorrhagic fever from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a Ebola hemorrhagic fever sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a Ebola hemorrhagic fever from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a Ebola hemorrhagic fever passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a Ebola hemorrhagic fever between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a Ebola hemorrhagic fever, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a Ebola hemorrhagic fever is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "diagnosis-and-criteria", "name": "Diagnosis, criteria and coding", "description": "What makes a case of Ebola hemorrhagic fever a case, and under which revision.", "rationale": "Criteria change between revisions, so a diagnosis without its coding revision cannot be compared with a later one.", "layers": [ { "id": "criteria", "name": "Diagnostic criteria", "description": "The criteria in force and who issues them.", "findings": [ { "id": "criteria-record", "name": "Criteria, issuer and revision", "description": "What must be true for a diagnosis, according to whom.", "questions": [ { "id": "criteria-record-q01", "text": "What criteria define Ebola hemorrhagic fever, issued by which body, in which revision?", "kind": "definition" }, { "id": "criteria-record-q02", "text": "What changed between revisions that would reclassify existing cases?", "kind": "boundary" } ] } ] }, { "id": "coding", "name": "Coding and terminology", "description": "The codes used to record it and their mapping.", "findings": [ { "id": "coding-record", "name": "Codes and mappings", "description": "Which classification codes apply and how they map.", "questions": [ { "id": "coding-record-q01", "text": "Which classification and terminology codes cover Ebola hemorrhagic fever, and how do they map to each other?", "kind": "definition" }, { "id": "coding-record-q02", "text": "What is lost when a case is mapped from one scheme to another?", "kind": "boundary" } ] } ] } ] }, { "id": "course-and-population", "name": "Course, population and care", "description": "How Ebola hemorrhagic fever develops, whom it affects, and what is done about it.", "rationale": "The condition, the diagnosis and the episode of care are three different things, and an agent must not merge them.", "layers": [ { "id": "course", "name": "Course and stages", "description": "Onset, progression, remission and outcome.", "findings": [ { "id": "course-record", "name": "Stages and transitions", "description": "The stages recorded and what moves a case between them.", "questions": [ { "id": "course-record-q01", "text": "What course does Ebola hemorrhagic fever typically take, and what marks each stage?", "kind": "definition" }, { "id": "course-record-q02", "text": "What separates the condition itself from an episode of care for it?", "kind": "boundary" } ] } ] }, { "id": "population", "name": "Affected populations", "description": "Who is affected, how often, and on what evidence.", "findings": [ { "id": "epidemiology", "name": "Prevalence and its basis", "description": "Rates with their population, period and source.", "questions": [ { "id": "epidemiology-q01", "text": "What prevalence or incidence is reported for Ebola hemorrhagic fever, in which population and period?", "kind": "measurement" }, { "id": "epidemiology-q02", "text": "What may an agent not conclude about an individual from a population rate?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a Ebola hemorrhagic fever came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a Ebola hemorrhagic fever and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a Ebola hemorrhagic fever is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a Ebola hemorrhagic fever, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a Ebola hemorrhagic fever, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a Ebola hemorrhagic fever is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 5, "layers": 10, "findings": 12, "questions": 32 } } } }